Shanghai Yihao Biotechnology Co., Ltd. is located in Shanghai Juke Biological Park. It is committed to becoming a practitioner in the field of cell therapy in China, regarding “improving innovative tumor immunotherapy technology”as a concept, an attitude, and a kind of pursuit in order to provide a cutting-edge and accurate treatment plan for cancer patients.
It is mainly engaged in the development and application of CAR-T, stem cells, and gene editing technology in cancer. The company was founded by the team of the returnees scientists with the international first-class level GMP cell preparation, molecular biology, and cell biology laboratory as well as a 1,000 square meter SPF Laboratory Animal Center. At present, the company has established good cooperation with many top-level scientific research institutes and clinics at home and abroad.